Kenneth C. Frazier
Executive Chair at Merck & Co.; Director at Eikon Therapeutics. Based in Millbrae, California.
- Rank
- 1564th of 14,644
- Companies held
- 2
- Largest holding
- MRK, 99.4% of total
- Latest SEC filing
- Feb 4, 2026
What the $94.8M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Merck & Co. MRK Common Stock | Directly | 700,653 | $132.81 | $93.1M | 98.2% | Form 4, Nov 7, 2022 |
| Merck & Co. MRK Common Stock - 401(k) Plan | Through 401(k) | 4,481 | $132.81 | $595K | 0.6% | Form 4, Nov 7, 2022 |
| Merck & Co. MRK Common Stock - 401(k) Plan | Indirectly (see filing footnote) | 4,444 | $132.81 | $590K | 0.6% | Form 4, Aug 3, 2022 |
| Eikon Therapeutics EIKN Common Stock | Directly | 111,111 | $4.76 | $529K | 0.6% | Form 4, Feb 4, 2026 |
Share counts are the amounts Kenneth C. Frazier reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1561 | Fred P. Lampropoulos Executive Chairman, Merit Medical Systems. South Jordan, UT | $95.1M |
| 1562 | Amit Agarwal Director, Datadog. New York, NY | $95.0M |
| 1563 | Glenn D. Fogel CEO AND PRESIDENT, Booking Holdings. Norwalk, CT | $94.8M |
| 1564 | Kenneth C. Frazier Executive Chair, Merck & Co.. Millbrae, CA | $94.8M |
| 1565 | April Kaye Bullock Anthony CEO & President, Home Health, Encompass Health. Dallas, TX | $94.6M |
| 1566 | Timothy Vanderhook CEO and Chairman, Viant Technology. Irvine, CA | $94.6M |
| 1567 | Gwen H. Booth Chief Operating Officer, LifeStance Health Group. Scottsdale, AZ | $94.5M |
Other Merck & Co. insiders
All MRK insiders- Robert M. Davis$59.8MChairman, CEO & President. #2190 overall
- Sanat Chattopadhyay$34.3MExe V-P & Pres. MMD. #3388 overall
- Richard R. DeLuca, Jr$15.4MEVP&Pres, Merck Animal Heallth. #6321 overall
- Dean Y. Li$12.5MExecutive VP & President, MRL. #4829 overall
- Caroline Litchfield$12.3MEVP & CFO. #7541 overall
- Julie L. Gerberding$6.5MEVP, Chief Patient Officer. #12086 overall
Questions
How much stock does Kenneth C. Frazier own?
Kenneth C. Frazier holds $94,767,956 in listed stock based on SEC filings and current prices, mostly Merck & Co. (MRK). That ranks 1564th on the Stock Rich List.
Is this Kenneth C. Frazier's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Kenneth C. Frazier last buy or sell stock?
The most recent open-market trade on file is a purchase of 111,111 EIKN shares on Feb 4, 2026 at $18.00.